source
- Health tech firms eye consumer-driven future at HLTH conference in Las VegasThe Endpoints team attended the HLTH conference in Las Vegas despite a ground stop on Friday, gathering insights on health technology trends. Observations suggest the industry is shifting toward c…
- J&J to acquire Ollin Biosciences for $2.2 billion to advance bispecific eye drug OLN324 against Roche’s VabysmoJohnson & Johnson announced it will buy Ollin Biosciences for an upfront $2.2 billion, with additional regulatory and commercial milestones that could bring total payments to about $3.3 billion. O…